Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

NCT00472004 ↗

Phase 4 Completed 204 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a Phase IV prospective, randomized, open label, comparative, multicenter study in generally healthy postmenopausal women receiving Totelle (17B Estradiol/TMG CC (1mg)) and Livial (Tibolone).

Timeline

Start: 2006-02
Primary completion: 2009-12
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Estradiol	Other / unclassified	1 mg	—
Comparator	Tibolone	Other / unclassified	2.5 mg	—
Comparator	Trimegestone	Small molecule	0.125 mg	—

Indications

No indication recorded.